tiprankstipranks
Diatreme Resources Limited (AU:DRX)
ASX:DRX
Australian Market
Want to see AU:DRX full AI Analyst Report?

Diatreme Resources Limited (DRX) AI Stock Analysis

3 Followers

Top Page

AU:DRX

Diatreme Resources Limited

(Sydney:DRX)

Select Model
Select Model
Select Model
Neutral 46 (OpenAI - 5.2)
Rating:46Neutral
Price Target:
AU$0.01
▼(-45.00% Downside)
Action:Reiterated
Date:06/19/26
The score is held down primarily by weak financial performance (unstable revenue, operating losses, and persistent negative operating/free cash flow), alongside bearish technicals (price below key moving averages and negative MACD). A solid low-leverage balance sheet provides some support, but valuation is also constrained by a negative P/E and no stated dividend yield.
Positive Factors
Low leverage / strong balance sheet
The company’s low debt and sizable equity base provide a durable financial cushion that reduces bankruptcy risk and preserves optionality. Over 2–6 months this balance-sheet strength supports funding for exploration and development, allows access to capital on better terms, and gives time to pursue commercialization without immediate solvency pressure.
Negative Factors
Persistent negative cash flow
Sustained operating and free cash-flow deficits create a structural reliance on external financing to fund operations and development. This undermines self-funded growth prospects, increases dilution or refinancing risk, and constrains ability to invest in mine development or commercialisation without clear near-term cash-flow improvement.
Read all positive and negative factors
Positive Factors
Negative Factors
Low leverage / strong balance sheet
The company’s low debt and sizable equity base provide a durable financial cushion that reduces bankruptcy risk and preserves optionality. Over 2–6 months this balance-sheet strength supports funding for exploration and development, allows access to capital on better terms, and gives time to pursue commercialization without immediate solvency pressure.
Read all positive factors

Diatreme Resources Limited (DRX) vs. iShares MSCI Australia ETF (EWA)

Diatreme Resources Limited Business Overview & Revenue Model

Company Description
Diatreme Resources Limited is an Australian company dedicated to the exploration and identification of various mineral resources, including heavy mineral sands, copper, gold, and other base metals. Its primary undertaking is the Galalar Silica San...
How the Company Makes Money
null...

Diatreme Resources Limited Financial Statement Overview

Summary
Balance sheet strength (low leverage and stable equity) supports resilience, but this is outweighed by weak operating quality: very small/volatile revenue (including zero revenue in 2025), recurring operating losses (negative EBIT in most years and negative EBITDA in 2024–2025), and persistently negative operating and free cash flow indicating ongoing cash burn and reliance on external funding.
Income Statement
22
Negative
Balance Sheet
78
Positive
Cash Flow
24
Negative
BreakdownDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue0.00886.46K468.51K110.14K23.94K
Gross Profit-306.60K886.46K254.29K-61.14K-77.02K
EBITDA-3.00M-4.61M10.70M-2.94M-1.94M
Net Income-744.96K-439.53K10.37M4.98M-2.15M
Balance Sheet
Total Assets94.51M95.45M66.53M55.33M33.14M
Cash, Cash Equivalents and Short-Term Investments2.34M5.19M10.77M13.64M6.50M
Total Debt1.05M1.20M1.75M1.54M1.61M
Total Liabilities2.23M2.51M2.96M2.59M2.37M
Stockholders Equity92.28M92.94M63.57M52.75M30.76M
Cash Flow
Free Cash Flow-2.40M-7.71M-2.80M-9.57M-8.70M
Operating Cash Flow-2.39M-6.00M-2.32M-2.51M-2.15M
Investing Cash Flow-549.08K1.06M-462.49K-6.95M-6.57M
Financing Cash Flow92.22K-643.79K-86.47K16.60M9.43M

Diatreme Resources Limited Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.02
Price Trends
50DMA
0.02
Negative
100DMA
0.02
Negative
200DMA
0.02
Negative
Market Momentum
MACD
>-0.01
Positive
RSI
0.00
Negative
STOCH
-73.33
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:DRX, the sentiment is Negative. The current price of 0.02 is above the 20-day moving average (MA) of 0.02, above the 50-day MA of 0.02, and above the 200-day MA of 0.02, indicating a bearish trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 0.00 is Negative, neither overbought nor oversold. The STOCH value of -73.33 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:DRX.

Diatreme Resources Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
53
Neutral
AU$90.49M-43.91-4.91%25.21%
47
Neutral
AU$87.98M11.359.11%
46
Neutral
AU$65.11M-157.71-0.41%
46
Neutral
AU$69.95M-4.59-16.67%42.00%
41
Neutral
AU$81.45M-11.80-9.03%-78.48%52.16%
41
Neutral
AU$78.56M-1.29-67.75%69.69%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AU:DRX
Diatreme Resources Limited
0.01
>-0.01
-45.00%
AU:AGY
Argosy Minerals
0.06
0.05
306.67%
AU:BSX
Blackstone Minerals Ltd
0.04
-0.05
-55.32%
AU:E25
Element 25 Limited
0.24
0.00
0.00%
AU:HAS
Hastings Technology Metals Limited
0.33
0.06
23.11%
AU:NNL
Nordic Nickel Limited
0.23
0.16
228.57%

Diatreme Resources Limited Corporate Events

Diatreme installs Brian Flannery as chair to steer advancing silica sands projects
Jun 16, 2026
Diatreme Resources Limited, an emerging Australian producer and explorer of mineral and silica sands, focuses on high-purity, low-iron silica products from projects in Far North Queensland and zircon from Western Australia’s Eucla Basin. The...
Diatreme Finalises Cape Flattery Silica Sale to Sibelco Joint Venture
Jun 9, 2026
Diatreme Resources has completed the sale of its Cape Flattery Silica Project vehicle, Cape Flattery Silica Pty Ltd, to Cape Silica Holdings Pty Ltd, the joint venture company it shares with Sibelco. Under the deal, Metallica Minerals sold 100% of...
Diatreme extends $1m debt facility to fund flagship silica projects
Jun 2, 2026
Diatreme Resources has secured a 12-month extension of its existing A$1.0 million unsecured debt facility, pushing the maturity date to 30 May 2027 on unchanged terms, including a 7.5% annual interest rate. The refinancing extends a facility origi...
Diatreme Clears All AGM Resolutions, Greenlights Cape Flattery Silica JV Deal
May 29, 2026
Diatreme Resources Limited reported that all seven resolutions put to shareholders at its 29 May 2026 annual general meeting were passed by poll. The strong support included approval of the remuneration report, the re‑election of director Ch...
Diatreme pushes Northern Silica Project toward production amid surging solar demand
May 29, 2026
Diatreme Resources reported progress on its Northern Silica Project in North Queensland, lodging a draft environmental impact statement and expanding its silica sand resources to more than 530 million tonnes of high-purity, low-iron material. The ...
Diatreme Resources Simplifies Capital Structure as 30 Million Options Expire
May 27, 2026
Diatreme Resources Limited has reported the expiry of three series of listed options on 27 May 2026, covering a total of 29,999,, , shares equivalent in options that lapsed without being exercised. The cessation of these options, with exercise pri...
Diatreme lodges updated corporate governance statement and Appendix 4G
Apr 29, 2026
Diatreme Resources Limited has lodged its updated corporate governance statement for the financial year ending 31 December 2025, confirming that the document is current as of 29 April 2026 and approved by the board. The company has also filed the ...
Diatreme Resources Details Board and Leadership Structure in Annual Report
Apr 29, 2026
Diatreme Resources Limited has released its annual report, highlighting its current corporate governance structure and key board appointments. The report lists former Australian Treasurer Wayne Swan as non-executive chair, supported by a board inc...
Diatreme Sets 2026 AGM as Expert Backs Fairness of Proposed Transaction
Apr 29, 2026
Diatreme Resources has called its annual general meeting for 29 May 2026 in Brisbane, where shareholders will receive the 2025 financial statements and vote on the non-binding remuneration report. The company has also commissioned an independent e...
Diatreme bolsters balance sheet as it advances Northern Silica flagship
Apr 26, 2026
Diatreme Resources reported its full-year statutory accounts for 2025, highlighting progress across its portfolio of critical mineral projects, with a strong emphasis on advancing the Northern Silica Project. The company also continued to develop ...
Diatreme drilling results bolster Queensland silica sand pipeline
Mar 25, 2026
Diatreme Resources has reported favourable aircore drilling results from its Si2 and Casuarina deposits within the Northern Silica Project, with 83 holes completed over 2,035 metres in the 2025 campaign. The data from Si2 extends the existing geol...
Diatreme boosts Cyclone mineral sands outlook with major recovery gains
Mar 19, 2026
Diatreme Resources has reported completion of metallurgical testwork and flowsheet optimisation for the Cyclone Project’s processing plants, delivering substantially higher projected recoveries and product yields. The work by Mineral Technol...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jun 19, 2026